The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Neuropathic pain is caused by a primary lesion or dysfunction of the nervous system and
can occur in the cornea. However, neuropathic corneal pain (NCP) is currently an ill-defined …

Dry eye disease (DED) is a multifactorial ocular surface disorder arising from numerous
interrelated underlying pathologies that trigger a self-perpetuating cycle of instability …

The use of blood-based eye drops as therapy for various diseases of the ocular surface has
become increasingly popular in ophthalmic practice during recent years. The rationale for …

A protocol for processing amniotic membrane as an extract to be re-hydrated and
administered topically as eye drops (amniotic membrane extract eye drops, AMEED) has …

Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular
surface diseases not improved by conventional therapy. Methods. We analyzed two …

Purpose: The objective was to provide preliminary information about the efficacy and safety
of immunologically safe plasma rich in growth factor (immunosafe PRGF) eye drops in the …

Purpose: The aim of the study was to compare the difference in composition between 100%
autologous serum (AS) and 100% platelet-rich plasma (PRP) eye drops and assess their …

Objective: To examine the evidence for the role of autologous serum eye drops (ASD) in
disease of the ocular surface. Methods: A search of the literature published through May …

Purpose: Preliminary information about the safety and efficacy of plasma rich in growth
factors (PRGF) eyedrops in the treatment of refractory cases of diverse ocular surface …